HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan Scicinski Selected Research

1-bromoacetyl-3,3-dinitroazetidine

5/2012Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan Scicinski Research Topics

Disease

28Neoplasms (Cancer)
11/2017 - 05/2012
8Hypoxia (Hypoxemia)
08/2016 - 05/2012
4Hemorrhagic Shock
07/2016 - 01/2015
4Malaria
07/2016 - 05/2015
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2016 - 01/2016
3Sickle Cell Anemia (Hemoglobin S Disease)
07/2016 - 01/2016
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2016 - 01/2016
2Colorectal Neoplasms (Colorectal Cancer)
11/2017 - 01/2015
2Brain Neoplasms (Brain Tumor)
04/2016 - 03/2016
2Melanoma (Melanoma, Malignant)
04/2016 - 03/2016
2Lung Neoplasms (Lung Cancer)
01/2016 - 01/2016
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2016 - 09/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2017
1Ewing Sarcoma (Sarcoma, Ewing)
11/2017
1Colonic Neoplasms (Colon Cancer)
01/2017
1Ischemia
08/2016
1Leishmaniasis
07/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2016
1Neoplasm Metastasis (Metastasis)
04/2016
1Flushing
09/2015
1Diarrhea
09/2015
1Carcinoid Tumor (Carcinoid)
09/2015
1Pain (Aches)
09/2015
1Virus Diseases (Viral Diseases)
08/2015
1Cerebral Malaria
05/2015
1Inflammation (Inflammations)
05/2015
1Infections
05/2015
1Glucosephosphate Dehydrogenase Deficiency
05/2015
1Methemoglobinemia
01/2015
1Necrosis
01/2015

Drug/Important Bio-Agent (IBA)

23RRx-001IBA
11/2017 - 09/2012
12Antineoplastic Agents (Antineoplastics)IBA
11/2017 - 05/2012
6Oxygen (Dioxygen)IBA
11/2017 - 08/2015
5NitrogenIBA
11/2017 - 08/2015
5Cisplatin (Platino)FDA LinkGeneric
05/2016 - 05/2012
4Pharmaceutical PreparationsIBA
11/2017 - 05/2014
4PlatinumIBA
05/2016 - 01/2016
4Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2015 - 04/2014
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 01/2014
3NitritesIBA
08/2016 - 01/2014
3Etoposide (VP 16)FDA LinkGeneric
05/2016 - 01/2016
2AntioxidantsIBA
11/2017 - 08/2015
2MethyltransferasesIBA
01/2017 - 10/2014
2Hemoglobins (Hemoglobin)IBA
08/2016 - 01/2015
2Radiation-Sensitizing AgentsIBA
04/2016 - 05/2012
2EnzymesIBA
01/2016 - 08/2015
2Histones (Histone)IBA
12/2015 - 09/2015
1Sulfhydryl Compounds (Thiols)IBA
11/2017
1Serum AlbuminIBA
11/2017
1Contrast MediaIBA
11/2017
1Antiviral Agents (Antivirals)IBA
01/2017
1NADP (NADPH)IBA
01/2017
1Monoclonal AntibodiesIBA
01/2017
1Nitric Oxide Synthase (NO Synthase)IBA
08/2016
1Biomarkers (Surrogate Marker)IBA
06/2016
1Reactive Nitrogen SpeciesIBA
04/2016
1ErbB Receptors (EGF Receptor)IBA
01/2016
1pimonidazoleIBA
01/2016
1Pemetrexed (MTA)FDA Link
01/2016
1NivolumabIBA
01/2016
1Tyrosine Kinase InhibitorsIBA
01/2016
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1Hormones (Hormone)IBA
01/2016
1NeuropeptidesIBA
01/2016
1Nitrogen OxidesIBA
01/2016
1Oxidoreductases (Dehydrogenase)IBA
01/2016
1Carboplatin (JM8)FDA LinkGeneric
01/2016
1SynaptophysinIBA
01/2016
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2016
1Chromogranin AIBA
01/2016
1Nitric Oxide DonorsIBA
12/2015
1Lysine (L-Lysine)FDA Link
09/2015
1Peptides (Polypeptides)IBA
09/2015
1Firefly LuciferasesIBA
08/2015
1Renilla LuciferasesIBA
08/2015
1dl1520 (ONYX-015)IBA
08/2015
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
05/2015
1Antimalarials (Antimalarial Agents)IBA
05/2015
1ArtemetherFDA Link
05/2015
1artemisinin (artemisinine)IBA
05/2015
1Heme (Haem)IBA
05/2015
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2015
1Irinotecan (Camptosar)FDA LinkGeneric
01/2015
1Cetuximab (Erbitux)FDA Link
01/2015
1Bevacizumab (Avastin)FDA Link
01/2015
1regorafenibIBA
01/2015
1nitric-oxide reductase (nitric oxide reductase)IBA
01/2015
1Panitumumab (Vectibix)FDA Link
01/2015
1Histone Deacetylase InhibitorsIBA
10/2014
1glycidyl nitrateIBA
05/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2014
1CarcinogensIBA
04/2014
1Transcription Factors (Transcription Factor)IBA
04/2014

Therapy/Procedure

14Therapeutics
01/2017 - 05/2012
8Drug Therapy (Chemotherapy)
01/2017 - 01/2014
5Radiotherapy
04/2016 - 05/2014
3Immunotherapy
01/2017 - 01/2016
1Retreatment
05/2016
1Blood Transfusion (Blood Transfusions)
01/2015
1Resuscitation
01/2015